News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
274,088 Results
Type
Article (14282)
Company Profile (105)
Press Release (259693)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (88340)
Career Advice (465)
Deals (15403)
Drug Delivery (73)
Drug Development (36749)
Employer Resources (50)
FDA (6383)
Job Trends (6237)
News (150802)
Policy (14134)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (445)
Accelerated approval (13)
Adcomms (8)
Allergies (67)
Alliances (23345)
ALS (56)
Alzheimer's disease (478)
Antibody-drug conjugate (ADC) (100)
Approvals (6575)
Artificial intelligence (202)
Autoimmune disease (41)
Automation (12)
Bankruptcy (150)
Best Places to Work (4375)
BIOSECURE Act (9)
Biosimilars (118)
Biotechnology (40)
Bladder cancer (38)
Brain cancer (30)
Breast cancer (172)
Cancer (1319)
Cardiovascular disease (152)
Career advice (418)
Career pathing (13)
CAR-T (50)
CDC (6)
Cell therapy (152)
Cervical cancer (9)
Clinical research (32043)
Collaboration (731)
Compensation (326)
Complete response letters (33)
COVID-19 (782)
CRISPR (43)
C-suite (435)
Cystic fibrosis (58)
Data (1829)
Denatured (18)
Depression (45)
Diabetes (126)
Diagnostics (1384)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (116)
Drug pricing (114)
Drug shortages (12)
Duchenne muscular dystrophy (82)
Earnings (33509)
Editorial (20)
Employer branding (4)
Employer resources (46)
Events (39038)
Executive appointments (529)
FDA (7485)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (439)
Gene editing (72)
Generative AI (18)
Gene therapy (167)
GLP-1 (440)
Government (1406)
Grass and pollen (4)
Guidances (164)
Healthcare (3593)
HIV (11)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (70)
Immuno-oncology (14)
Indications (53)
Infectious disease (846)
Inflammatory bowel disease (73)
Inflation Reduction Act (7)
Influenza (24)
Intellectual property (113)
Interviews (60)
IPO (5919)
IRA (33)
Job creations (2055)
Job search strategy (374)
JPM (28)
Kidney cancer (9)
Labor market (28)
Layoffs (205)
Leadership (8)
Legal (3450)
Liver cancer (22)
Longevity (8)
Lung cancer (184)
Lymphoma (123)
Machine learning (13)
Management (17)
Manufacturing (415)
MASH (67)
Medical device (1306)
Medtech (1314)
Mergers & acquisitions (9910)
Metabolic disorders (436)
Multiple sclerosis (48)
NASH (14)
Neurodegenerative disease (84)
Neuropsychiatric disorders (37)
Neuroscience (891)
Neurotech (1)
NextGen: Class of 2026 (1589)
Non-profit (605)
Now hiring (17)
Obesity (229)
Opinion (142)
Ovarian cancer (39)
Pain (110)
Pancreatic cancer (51)
Parkinson's disease (80)
Partnered (11)
Patents (221)
Patient recruitment (116)
Peanut (12)
People (29759)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8322)
Phase 2 (13531)
Phase 3 (12214)
Pipeline (1932)
Policy (135)
Postmarket research (1401)
Preclinical (3350)
Press Release (25)
Prostate cancer (84)
Psychedelics (16)
Radiopharmaceuticals (136)
Rare diseases (355)
Real estate (2659)
Recruiting (19)
Regulatory (10965)
Reports (15)
Research institute (574)
Resumes & cover letters (55)
Rett syndrome (6)
RNA editing (8)
RSV (20)
Schizophrenia (69)
Series A (83)
Series B (51)
Service/supplier (2)
Sickle cell disease (46)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (9)
Startups (1645)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (68)
The Weekly (45)
Vaccines (233)
Venture capital (32)
Weight loss (141)
Women's health (27)
Worklife (4)
Date
Today (29)
Last 7 days (167)
Last 30 days (694)
Last 365 days (10486)
2026 (993)
2025 (10762)
2024 (12532)
2023 (14284)
2022 (19596)
2021 (20097)
2020 (19063)
2019 (14891)
2018 (11719)
2017 (13892)
2016 (13132)
2015 (15476)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10889)
Location
Africa (318)
Alabama (19)
Alaska (1)
Arizona (77)
Arkansas (3)
Asia (20921)
Australia (2687)
California (3191)
Canada (1486)
China (554)
Colorado (144)
Connecticut (129)
Delaware (123)
Europe (40955)
Florida (601)
Georgia (63)
Hawaii (1)
Idaho (10)
Illinois (349)
India (46)
Indiana (241)
Iowa (2)
Japan (247)
Kansas (77)
Kentucky (20)
Louisiana (4)
Maine (2)
Maryland (422)
Massachusetts (2645)
Michigan (46)
Minnesota (165)
Mississippi (1)
Missouri (33)
Montana (8)
Nebraska (7)
Nevada (16)
New Hampshire (8)
New Jersey (1403)
New Mexico (7)
New York (909)
North Carolina (620)
North Dakota (2)
Northern California (1458)
Ohio (80)
Oklahoma (5)
Oregon (18)
Pennsylvania (716)
Puerto Rico (12)
Rhode Island (17)
South America (508)
South Carolina (10)
Southern California (1391)
Tennessee (53)
Texas (456)
United States (12759)
Utah (60)
Virginia (161)
Washington D.C. (42)
Washington State (225)
West Virginia (1)
Wisconsin (38)
Wyoming (1)
274,088 Results for "adare pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership
August 14, 2025
·
6 min read
Press Releases
ADAR1 Announces ISS Recommends Keros Therapeutics Stockholders WITHHOLD Votes from Directors Dr. Mary Ann Gray and Dr. Alpna Seth
May 21, 2025
·
4 min read
Press Releases
ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist
December 11, 2024
·
6 min read
Business
Covant Therapeutics Debuts with Boehringer Partnership Targeting ADAR1
Boston-based Covant Therapeutics gained $10 million upfront in a deal with Boehringer Ingelheim to chase after a cancer immunotherapy target, ADAR1.
March 29, 2023
·
3 min read
·
Ana Mulero
Press Releases
Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy
October 10, 2024
·
2 min read
Genetown
Covant and Boehringer Ingelheim Collaborate to Develop a Novel ADAR1 Inhibitor for Use in Cancer Patients
Covant Therapeutics, an innovative covalent drug discovery company, has entered into an exclusive research collaboration and worldwide licensing agreement with Boehringer Ingelheim covering Covant’s ADAR1 program.
March 28, 2023
·
2 min read
Business
Adare Pharma Solutions Appoints Ludger Roedder as President, Adare Biome
Adare Pharma Solutions is excited to announce that Ludger Roedder has joined the organization as President of Adare Biome.
April 20, 2021
·
3 min read
Genetown
ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing
ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it has successfully defended against two oppositions that were filed against a key patent for its ADAR-mediated RNA editing platform Axiomer®.
March 14, 2023
·
5 min read
Press Releases
Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical
February 9, 2026
·
5 min read
Press Releases
Kiniksa Pharmaceuticals Provides Corporate Update
January 12, 2026
·
11 min read
1 of 27,409
Next
